Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders.

doi:10.5858/2002-126-1304-CUOFVL

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders.

Archives of pathology & laboratory medicine - 1 Nov 2002

Press Richard D, Bauer Kenneth A, Kujovich Jody L, Heit John A

Abstract excerpt

OBJECTIVE: To review the current state of the art regarding the role of the clinical laboratory in diagnostic testing for the factor V Leiden (FVL) thrombophilic mutation (and other protein C resistance disorders), and to generate, through literature reviews and opinions of recognized thought-leaders, expert consensus recommendations on methodology and diagnostic, prognostic, and management issues pertaining to...

Topics

Abortion, Habitual
Adult
Blood Coagulation Tests
Evidence-Based Medicine
Factor V
Female
Genetic Predisposition to Disease
Genetic Testing
Humans
Male
Mutation
Practice Guidelines as Topic
Pregnancy
Thromboembolism
Thrombophilia

Source

Open in PubMed

Identifiers

PMID: 12421138
DOI: 10.5858/2002-126-1304-CUOFVL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics